• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASTMH 2015

25-29 October 2015

Philadelphia, United States

American Society of Tropical Medicine and Hygiene (ASTMH), 64th Annual Meeting

ASTMH, founded in 1903, is a worldwide organization of scientists, clinicians and program professionals whose mission is to promote global health through the prevention and control of infectious and other diseases that disproportionately afflict the global poor. Research, health care and education are the central activities of ASTMH members, whose work bridges basic laboratory research to international fieldwork and clinics to country-wide programs.

The Annual Meeting is a dynamic forum for the exchange of the latest scientific and clinical advances in tropical medicine and global health.

DNDi Medical Director, Nathalie Strub Wourgaft, spoke in a session on clinical experience in treating neglected infectious tropical diseases.

Download DNDi @ ASTMH 2015

Symposium #172

CURE: FDA-NIH effort to capture the global clinical experience of treating neglected infectious diseases (including neglected tropical diseases and emerging threats) in new ways

The Landscape of drug development for neglected tropical diseases
Nathalie Strub Wourgaft, Medical Director, DNDi
Launch of a system to capture clinical drug repurposing for neglected infectious diseases
Heather Stone, Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States
Accessing and collecting global data directly from clinicians in the field using mobile technologies
Bob Bollinger, Center for Clinical Global Health Education, Johns Hopkins School of Medicine, Baltimore, MD, United States
A User’s Perspective: A clinician’s experience with drug repurposing for neglected infectious diseases
Philip Alexander, Lady Willingdon Hospital, Manali, India
Panel Discussion
Noel Southall, Panel Participant, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, United States

Poster Session Presentations

Poster Session Presentations

Poster Session A Presentations

Building an enabling environment for scaling up access in Chagas – Bridging the gap between patients and treatment through a partnership model.
Carolina Batista, Andrea Marchiol.

Poster Session B Presentations

Innovation in neglected diseases – Lessons learned from the partnership for development of antimalarial combination therapy in Brazil.
Vera Lucia Luiza, Tayná Marques Torres Barboza, Gabriela Costa Chaves, Luciana de Paula Barros Gonçalves, Carolina Batista, Eric Stobbaerts.
Screening cascade for discovery programs aiming at the identification of new macrofilaricide agents for treatment of Onchocerciasis.
Simon Townson, Sabine Specht, Suzanne Gokool, James Metz, Schmitt R. J., Dale Kempf, Coralie Martin, Achim Hoerauf, Thomas von Geldern, Ivan Scandale.
 
The Perelman School of Medicine at the University of Pennsylvania hosted a panel discussion and reception on the need for R&D to develop new diagnostics, treatments, and vaccines for the millions of patients affected by onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis).
 
Speakers Included:
  • Samuel Wanji, University of Buea
  • Alexander Debrah, Kumasi Centre
  • Claudia Pena Rossi, Drugs for Neglected Diseases initiative (DNDi)
  • Tala de los Santos, PATH
  • Sara Lustigman, New York Blood Center
  • V. Kumaraswami, Indian Council of Medical Research
  • Luc E. Coffeng, Erasmus MC
  • Didier Bakajika, Sightsavers
  • Achim Hoerauf, University of Bonn
  • Robert Don, Drugs for Neglected Diseases initiative (DNDi)

Download Invitation

More information: ASTMH website

Poster Session Presentations

Filarial Diseases Side Event

Filarial Event ASTMH 2015

The Perelman School of Medicine at the University of Pennsylvania will host a panel discussion and reception on the need for research and development (R&D) to develop new diagnostics, treatments, and vaccines for the
millions of patients affected by onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis).

– 6:00pm Reception
– 6:30pm Program

SPEAKERS INCLUDED:

  • Samuel Wanji, University of Buea
  • Alexander Debrah, Kumasi Centre
  • Claudia Pena Rossi, Drugs for Neglected Diseases initiative(DNDi)
  • Tala de los Santos, PATH
  • Sara Lustigman, New York Blood Center
  • V. Kumaraswami, Indian Council of Medical Research
  • Luc E. Coffeng, Erasmus MC
  • Didier Bakajika, Sightsavers
  • Achim Hoerauf, University of Bonn
  • Robert Don, Drugs for Neglected Diseases initiative (DNDi)

Robert Austrian Auditorium and Lobby
The Perelman School of Medicine at the University of Pennsylvania
Clinical Research Building
1st Floor
415 Cure Blvd
Philadelphia, PA 19104

Download Invitation

This event was co-organized by:

Sponsors

Other events

Loading...
16 July 2025, 1 PM Khartoum

Online webinar

Mycetoma: a neglected disease affecting thousands of people

25 June 2025, 12:30 PM Brazil

Online webinar

NTDs around the world – Colombia

18 June 2025

Online

Antiviral Drug Discovery (AViDD) Open Science Forum

16-18 June 2025

São Paulo, Brazil

SciBiz Conference 2025

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License